NeutraSal Treatment for Xerostomia in OSAS Patients Using CPAP Therapy

Completed 32 enrolled Medical University of South Carolina Invado Pharmaceuticals LLC · collab

RandomizedParallel-groupDouble-blindPrevention

Summary

To assess whether the daily use of NeutraSal will prevent or reduce dry mouth in patients undergoing CPAP therapy for OSAS and improve CPAP compliance

Timeline

Start: 2013-11
Primary completion: 2015-04-10
Completion: 2017-07-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	NeutraSal	Unknown	—	Oral

Indications

No indication recorded.